-
ATXS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Astria Therapeutics (ATXS)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 80.90 mm | 80.90 mm | 80.90 mm | 80.90 mm | 80.90 mm | 80.90 mm |
Cash burn (monthly) | 30.43 mm | 4.44 mm | 9.67 mm | 8.97 mm | 133.33 k | 5.33 mm |
Cash used (since last report) | 85.22 mm | 12.42 mm | 27.09 mm | 25.12 mm | 373.48 k | 14.94 mm |
Cash remaining | -4.32 mm | 68.48 mm | 53.81 mm | 55.78 mm | 80.53 mm | 65.96 mm |
Runway (months of cash) | -0.1 | 15.4 | 5.6 | 6.2 | 603.9 | 12.4 |
13F holders | Current |
---|---|
Total holders | 101 |
Opened positions | 36 |
Closed positions | 22 |
Increased positions | 31 |
Reduced positions | 23 |
13F shares | Current |
---|---|
Total value | 504.95 bn |
Total shares | 61.63 mm |
Total puts | 29.70 k |
Total calls | 22.70 k |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
Perceptive Advisors | 6.49 mm | $59.02 bn |
FMR | 6.05 mm | $55.10 bn |
Ra Capital Management | 5.04 mm | $45.90 bn |
TCG Crossover GP II | 4.37 mm | $33.73 mm |
VR Adviser | 3.61 mm | $32.84 bn |
Fairmount Funds Management | 3.55 mm | $32.34 bn |
BLK BlackRock | 3.52 mm | $32.01 bn |
Vestal Point Capital | 3.25 mm | $29.58 bn |
TCG Crossover Management | 2.76 mm | $25.13 bn |
Vanguard | 2.59 mm | $23.57 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jun 24 | Bate Kenneth | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |
5 Jun 24 | Lapointe Anthony Gregg | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |
5 Jun 24 | Cole Hugh M | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |
5 Jun 24 | Fred Callori | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |
5 Jun 24 | Jonathan Violin | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |